Trends and dynamics of HIV infection among the female population in 2016-2024
DOI:
https://doi.org/10.15574/HW.2026.1(182).59Keywords:
human immunodeficiency virus (HIV), women, morbidity, dynamics, epidemiologyAbstract
Human immunodeficiency virus (HIV) remains one of the leading medical and social problems of our time, characterized by the steady circulation of the pathogen and the uneven dynamics of morbidity among different population groups. Special attention is paid to the female population, in which the epidemic process has specific socio-biological features related to demographic, behavioral and availability of medical services, factors affecting the level of detection and spread of infection, as well as the effectiveness of preventive measures and early diagnosis, timely treatment, and control of the course of the disease.
Aim - to analyze the trends and dynamics of registered cases of HIV infection among the female population in Ukraine in 2016-2024.
Materials and methods. A retrospective descriptive epidemiological study was conducted based on official statistical data of the Public Health Center of the Ministry of Health of Ukraine. Methods of descriptive statistics, comparative and dynamic analysis with assessment of absolute indicators and rates of their changes in the temporal aspect were used.
Results. It was established that in the years 2016-2022, there was a tendency towards a gradual increase in the number of registered HIV cases among women from 62,576 to 72,714 cases, reaching a peak value in 2022. In 2019, a slight decrease in the indicator was noted, which may indicate a temporary stabilization of the epidemic process. In 2023, a slight decrease in the number of cases was recorded, while in 2024, there was a sharp decrease in the indicator to 62,968. The revealed dynamics have a wave-like character with periods of growth, stabilization, and decline.
Conclusions. The obtained results indicate the presence of an unstable epidemiological situation regarding HIV infection among the female population, with an upward trend in 2016-022 and a further sharp decrease in 2024. The identified changes can be due to both real shifts in the epidemic process and the influence of external social and organizational factors, which require further comprehensive analysis.
No conflict of interests was declared by the authors.
References
Atowoju I, Dawer P, Asrani M, Panjiyar B. (2024, Jul). Impact of maternal HIV infection on perinatal outcomes: A systematic review. Int J Gynaecol Obstet. 166(1): 35-43. https://doi.org/10.1002/ijgo.15528; PMid:38573155
De Waard L, Langenegger E, Erasmus K, Van der Merwe T, Olivier SE, Du Toit N et al. (2021, Dec 2). Maternal and neonatal outcomes of COVID-19 in a high-risk pregnant cohort with and without HIV. S Afr Med J. 111(12): 1174-1180. https://doi.org/10.7196/SAMJ.2021.v111i12.15683; PMid:34949304
Dude AM, Jones M, Wilson T. (2023, Jun). Human Immunodeficiency Virus in Pregnancy. Obstet Gynecol Clin North Am. 50(2): 389-399. https://doi.org/10.1016/j.ogc.2023.02.010; PMid:37149318
Feger OV, Pohoriliak RY, Kalii VV, Kozar OM. (2025). Dynamics of HIV prevalence among pregnant women in Ukraine in 2016-2024: regional analysis. Ukrainian Journal Health of Woman. 5(180): 21-26. https://doi.org/10.15574/HW.2025.5(180).2126; PMid:31489910
Gutema G, Tola HH, Fikadu D, Leta D, Bejiga B, Tura JB et al. (2023, Jun 6). Positivity rate, trend and associated risk factors of mother-to-child transmission of HIV among HIV-exposed infants. BMC Pediatr. 23(1): 283. https://doi.org/10.1186/s12887-023-04074-2; PMid:37280581 PMCid:PMC10245613
Karthigeyan KP, Binuya C, Vuong K, Permar SR, Nelson AN. (2024, Dec). Research on Maternal Vaccination for HIV Prevention. Clin Perinatol. 51(4): 769-782. https://doi.org/10.1016/j.clp.2024.08.007; PMid:39487019 PMCid:PMC11531644
Kumar N, Mangla M. (2022, Apr). 1Influence of paired pandemic of COVID-19 and HIV infection on pregnant women and children: A challenging issue. J Mother Child. 25(2): 123-126. doi: 10.34763/jmotherandchild.20212502.d-21-00017.
Lopes BB, Ramalho AKL, Oriá MOB, Cunha GHD, Aquino PS, Pinheiro AKB. (2023, Mar 27). Epidemiology of HIV in pregnant women and its relationship with the period of the COVID-19 pandemic. Rev Esc Enferm USP. 57: e20220339. https://doi.org/10.1590/1980-220x-reeusp-2022-0339en; PMid:36972324 PMCid:PMC10081587
Papadopoulos A, Thomas K, Protopapas K, Antonyak S, Begovac J, Dragovic G et al. (2023, Apr). HIV treatment strategies across Central, Eastern and Southeastern Europe: New times, old problems. HIV Med. 24(4): 462-470. https://doi.org/10.1111/hiv.13416; PMid:36196025
Ranzani A, Lapadula G, D'Aloia F, Ornaghi S, Locatelli A et al. (2025, Oct). Pregnancy in women living with HIV: Experience of IRCCS San Gerardo dei Tintori and a narrative review. New Microbiol. 48(3): 215-225.
Trindade LNM, Nogueira LMV, Rodrigues ILA, Guimarães RJPSE, Souza MHDN. (2023, Nov 20). Human immunodeficiency virus infection in pregnant women and its correlation with socioeconomic determinants. Rev Esc Enferm USP. 57: e20220321. https://doi.org/10.1590/1980-220x-reeusp-2022-0321en; PMid:37997877 PMCid:PMC10672042
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Ukrainian Journal Health of Woman

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.